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Abstract 
 
Background and aims: Our previous research reported islet stellate cell (ISC) 
exhibiting similar appearance to classical pancreatic stellate cell (PSC) was isolated 
from freshly isolated rat islets, which may contribute to the islet fibrosis in type 2 
diabetes mellitus (T2DM). This study was designed to determine whether human 
islets also contain ISC, and if so, whether human ISC is different from human PSC. 
Materials and methods: Using standard explants techniques, human ISC was 
isolated from freshly isolated human islets, while human PSC used as a positive 
control was isolated from pancreatic tissue. Immunofluorescence visualization of 
markers for PSC -smooth muscle actin (-SMA), desmin, vimentin, glial fibrillary 
acidic protein (GFAP)  was used to characterize the human ISC. Cell counting kit-8 
(CCK-8) was used to assess the proliferation of ISC. The wound-healing assay and 
the transwell migration were used to assess the migration capacity of ISC. 
Immunofluorescence against collagen typesⅠ(col-Ⅰ), collagen types Ⅲ (col-Ⅲ) 
and fibronectin (FN) was performed to identify extracellular matrix (ECM) 
component synthesized by ISC. Adipogenic and osteogenic differentiation were tried 
to detected stem cell potential. 
Results: After about 24 h in culture, an increasing number of ISC with triangular 
shape began to grow out from human islets. The passaged ISC expressed -SMA, 
desmin, vimentin, GFAP and was positive for col-Ⅰ, col-Ⅲ and FN. Compared with 
PSC, the proliferation and migration ability of ISC was significantly slower than those 
of PSC. And both the human PSC and ISC were able to differentiate in vitro into 
adipocyte- and osteoblast-like cells. Conclusion: Similar to our previous rat 
experiment, the current study shows that human islets also contain ISC which is 
phenotypically similar but not identical to human PSC. Activated human ISC is a high 
active ECM-producing cell type, indicating human ISC may contribute to islet fibrosis 
in patients with T2DM.    
Key words: Type 2 diabetes mellitus; T2DM; human islet; human ISC; islet stellate 
cell 
 
Introduction 
 
Type 2 diabetes mellitus (T2DM) is caused by a combination of genetic and 
environmental factors that result in decreased insulin function at sites of insulin action 
and a reduced ability of pancreatic beta cells to elevate insulin secretion in response to 
increased blood glucose levels. Although major progress has been achieved in our 
understanding of the pathogenesis of T2DM, the mechanisms underlying β-cell failure 
in T2DM are not fully understood.  
It has been reported in the late stage of T2DM, islet fibrosis is observed in humans 
and in animal models [1-7], which could further aggravate β-cell failure. Several 
recent studies observed activated pancreatic stellate cells (PSC) in the fibrotic islets, 
suggesting PSC might play an important role in this process [4, 8-11]. In health, PSC 
is quiescent and is characterized by cytoplasmic lipid droplets rich in vitamin A. But 
upon in response to pancreatic injury and inflammation or exposure to inflammatory 
cytokines or oxidant stress, PSC can be activated, starting to proliferate, change their 
morphology into myofibroblast-like cells, up-regulate the expression of -smooth 
muscle actin (α-SMA), and secrete extracellular matrix (ECM) components [12]. 
Since the first identification of PSC, numerous in vivo and in vitro studies have 
provided strong evidence of a central role of PSC in pancreatic fibrogenesis 
associated with chronic pancreatitis and pancreatic cancer [12-19]. 
However, we have reported that using standard explants techniques, we isolated rat 
islet stellate cell (ISC) from endocrine pancreatic islets [20]. Compared with rat PSC, 
ISC is more rapidly activated than PSC in vitro. They express PSC’s marker, 
-SMA, vimentin, glial fibrillary acidic protein (GFAP) and is positive for ECM 
components col-Ⅰ，col-Ⅲ and FN. But, ISC differed from PSC by having reduced 
rates of proliferation and migration in vitro. Our previous indicate isolated rat islets 
contain a population of stellate cells which are phenotypically similar but not identical 
to PSC. In view of the established role of PSC in pancreatic fibrosis, we suggest that 
these may contribute to islet fibrosis in T2DM. 
This study was designed to determine whether human islets also contain ISC, and if 
so, whether human ISC is different from human PSC. 
 
Methods and materials 
 
Human pancreatic tissue. Human pancreatic tissue was isolated from surgical 
samples, which was approved by the Zhongda Hospital Ethics Committee (Zhongda 
Hospital, Medical School, Southeast University, Jiangsu, China).  
Isolation and culture of human islets. Human islets were isolated from pancreatic 
tissue using collagenase P. Briefly, pancreatic tissue was cut into small tissue blocks 
and digested with 1.5 mg/ml collagenase P (Roche) at 37 C. Then human islets were 
handpicked under a stereomicroscope, as described previously [21]. The islets can be 
characterized by dithizone (DTZ) staining (0.1g/l, Sigma) [22]. Freshly isolated islets 
were subsequently cultured in cell culture dishes with 10 ml Dulbecco’s modified 
Eagle’s medium/Ham’s F12 (DMEM/F12, 1:1 v/v) with 10% fetal bovine serum (FBS, 
Gibco) at 37°C in a 5% CO2-air humidified atmosphere.  
Isolation and culture of human PSC. Human PSC was isolated from pancreatic 
tissue using explant techniques [23]. Briefly, human pancreatic tissue was cut into 
small tissue blocks (0.5-1mm3), which was seeded into cell culture dishes in the 
presence of 10% FBS in DMEM/F12. Tissue blocks were cultured at 37°C in a 5% 
CO2-air humidified atmosphere.  
Immunostaining. Human ISC and PSC were fixed in 4% PFA in PBS for 20 min at 
room temperature, subsequently, immunofluorescent staining for -SMA, desmin, 
vimentin, GFAP, Col-I, Col-III and FN was performed. Cells were incubated 
overnight at 4°C with primary antibody (Abcam, dilution rate: -SMA desmin, 
vimentin and GFAP, 1100; Col-I, Col-III and FN, 1200 ), followed by a 1 h 
treatment with secondary antibody (Jackson ImmunoResearch Laboratories, 1100). 
The sections in negative control group were incubated with PBS, instead of primary 
antibody. And the results indicated that the antibody and the staining worked well. 
Morphometric analyses were performed using Image J software. 
CCK-8 assay. Cell proliferation was determined with the CCK-8 kit (Keygen 
Biotech). Cells were suspended at a final concentration of 5103 cells/well and 
cultured in 96-well microplates for 24, 48 and 72 h, after which CCK-8 reagent (10 l) 
was added to each well containing 100 µl of culture medium and the plate was 
incubated for 1 h at 37 C. Viable cells were evaluated by A (A450nm) using auto 
microplate reader (Wellscan), such that A450nm was proportional to the rate of cell 
proliferation. All experiments were performed in quintuplicate on three separate 
occasions (n=15).  
Cell migration assays. The transwell migration assay was performed in 24-transwell 
plates using inserts with a pore size of 8 μm (Corning). 5103 stellate cells were 
serum-starved for 24 h, after which cells were cultured in serum-free medium in the 
inner compartment of the transwell insert, while the plate wells which received the 
inserts contained DMEM/F12 supplemented with 10% FBS. The cells were incubated 
for 24 h at 37 C, then fixed with 2% glutaraldehyde and stained with 1% crystal 
violet for 10 min. The cells that had not migrated through the membrane were 
removed. Cells adhering to the lower side of the insert membrane were visualized by 
light microscopy and counted manually (n=5).  
For the wound-healing assay, 5105 cells were seeded in 6-well culture plates and 
grown to reach confluence. After serum starvation for 24 h, the monolayers were 
wounded by scraping off a strip of cells with a 10 L pipette tip. After 24 h cells 
migrating into the wound boundaries were counted manually under a phase contrast 
microscope (n=5). 
Adipogenic and osteogenic differentiation. Adipogenic differentiation was induced 
by cultivation of confluent cultures in DMEM/F12 containing 20% (vol./vol.) FBS, 
2.5 g/ml insulin, 100 mol/l indomethacin, 5 mol/l rosiglitazone and 10 nmol/l 
dexamethasone. For osteogenic differentiation, confluent cultures were cultivated in 
DMEM/F12 containing 10% (vol./vol.) FBS, 10 mmol/l -glycerophosphate, 5 g/ml 
ascorbic acid and 10 nmol/l dexamethasone (Sigma). Cultures were maintained in 
differentiation media for 1 month with medium changes twice a week. Cell 
differentiation was analyzed by staining with Oil Red O or Alizarin Red S (Sigma) for 
adipogenic and osteogenic differentiation, respectively [24].  
Statistical analysis. Data were presented as the means ± SE. Statistical significance 
was determined by ANOVA or unpaired student’s t-test, as appropriate, and 
differences between group were considered to be statistically significant when P 
0.05. All of the statistical analyses were performed using the Statistical Product and 
Services Solutions (SPSS) package (Version 11.5, SPSS Science). 
 
Results 
 
Isolation and culture of human ISC from isolated human islets. After about 24 h 
in culture, human islets adhered to the bottom of culture dishes. Then an increasing 
number of cells with triangular shape and large nuclei began to grow out from the 
edge of human islets. These cells adhered to the culture dish and assumed a stellate 
appearance without any detectable lipid droplets in the cytoplasm (FIG.1). We have 
reported previously rat islets also contained a population of stellate cells and had 
similar phenomenon.  
A
Characterization of human ISC. Immunofluorescence visualization of markers for 
PSC -SMA, desmin, vimentin, GFAP was used to characterize the human ISC at 
passage 5. Figure 2 showed both human PSC and ISC (a-c, PSC; d-f, ISC) were 
positive for -SMA, desmin, vimentin and GFAP. 
Proliferation of human ISC. To assess the rate of cell proliferation of PSC and ISC 
(passage 5), we used the CCK-8 assay to measure the number of viable cells during a 
72 h culture period after seeding 2103 cells/well in 96-well microplates, as shown in 
Figure 5. After 24 h, there was no significant difference between the absorbance 
measurements at A450nm in PSC and ISC groups, which indicated the number of PSC 
and ISC were similar at this time point. By 48 h in culture the number of PSC was 
significantly greater than that of ISC, and this difference was further extended after 72 
h in culture, demonstrating that the ISC proliferated at a significantly slower rate than 
the PSC (FIG.3). 
Migration of human stellate cell populations Migration was assessed by the 
wound-healing assay and the transwell migration assay, which are well-established in 
vitro systems for measuring cell motility [25, 26].  
In wound healing assay, 24 h after the wound formation, the number of human ISC 
migrating into the cell-free area was significantly less than that of PSC (36.8 ± 7.6 % 
of control, P<0.01, FIG. 4).  
In accordance with this, ISC also showed less motility in the transwell migration 
assay. Thus, after 24 h the number of ISC migrating through the membrane was 
significantly less than that of PSC (12.3 ± 3.8 % of control, P<0.01, FIG.4), which 
confirmed the results observed in wound healing assay. 
ECM synthesis by human PSC and ISC. A panel of antibodies directed against 
different ECM components was used to assess the synthesis of col-Ⅰ, col-Ⅲ and FN 
by the stellate cell populations (passage 5). As shown in Figure 5, both PSC and ISC 
were immunopositive for col-Ⅰ, col-Ⅲ and FN, respectively.   
Adipogenic and osteogenic differentiation. Both the human PSC and ISC were able 
to differentiate in vitro into adipocyte- and osteoblast-like cells, as assessed by 
histological staining with Oil Red O or Alizarin Red S. Moreover, as shown in Figure 
6, the number of ISC differentiated into adipocyte- and osteoblast-like cells was more 
than that of PSC, which indicate human ISC was easier to be differentiate in vitro than 
PSC.  
 
Discussion 
 
In our previous rat research, using explant techniques, we isolated ISC exhibiting 
similar appearance to classical PSC from fresh isolated rat islets [20]. And 
immunofluorescent staining showed these out-growing cells were negative for insulin, 
so we excluded the possibility of -cell out-growth. In order to distinguish these cells 
from PSC, we named the stellate cells migrating out from islets as ISC. The rat 
experiment demonstrated that rat ISC expressed PSC’s marker and was 
immunopositive for col-Ⅰ, col-Ⅲ and FN, respectively. Moreover, compared with 
rat PSC, rat ISC was easier to be activated in vitro, and differed from PSC by having 
reduced rates of proliferation and migration in vitro [20]. 
Although we have demonstrated rat islets contained a population of stellate cells, 
which might contribute to the islet fibrosis in T2DM, we still have no idea whether 
human islets also contain these cells, and if so, whether human ISC is different from 
human PSC. Because T2DM has reached pandemic proportions, and current 
predictions show that this trend will continue [27, 28], achieving a better 
understanding of this complex disease is imperative. It is of great study value to figure 
out the answers to the above questions. 
we tried to use the same method to isolate human ISC from human islets. An 
increasing number of ISC with triangular shapes and large nuclei migrated out from 
the edge of human islets in culture. These cells adhered to the culture dish and had a 
stellate appearance without any detectable lipid droplets in the cytoplasm, indicating 
ISC could be activated soon in vitro. The phenomenon we observed from the human 
islets was similar to what we observed in the rat experiment [20]. PSC are 
characterized by a range of markers including -SMA, desmin, vimentin and GFAP 
[23, 29]. Here, human PSC was used as a positive control, immunofluorescent 
staining for -SMA, desmin, vimentin and GFAP was performed to identify ISC. 
Both of the passaged human PSC and human ISC were immunopositive for -SMA, 
desmin, vimentin and GFAP, so ISC should be included in stellate cell type.  
As we discussed previously, activated PSC is an highly active ECM-producing cell 
type, having the capacity to synthesize and secrete large amount of ECM component 
such as col-Ⅰ, col-Ⅲ and FN. And activated PSC cannot keep the balance between 
MMPs and TIMPS [30], which subsequently result in the pancreatic fibrosis 
associated with chronic pancreatitis and pancreatic cancer [12-19, 30]. It has been 
reported in the late stage of T2DM, islet fibrosis is observed in humans and in animal 
models [1-7], which is an end stage finding associated with the extracellular matrix 
(ECM)/collagen and fibronectin deposition [1]. Attenuation of islet fibrosis in animal 
model of T2DM could protect pancreatic β-cell and improve islet function [4]. Islet 
fibrosis could be important in the progression of pancreatic β-cell failure in T2DM.  
So figuring out the mechanisms responsible for the development of islet fibrosis is of 
great significance to the treatment of T2DM, which could be a potential target to treat 
T2DM. In this study, passaged ISC was immunopositive for col-Ⅰ, col-Ⅲ and FN, 
and there was no significant difference between PSC and ISC, suggesting similar to 
PSC, activated human ISC should also be a highly active ECM-producing cell type. 
So we speculate in health, human ISC normally exist in the islet in a quiescent 
(non-activated) state. But upon exposure to injurious stimuli such as inflammatory 
cytokines, oxidant stress or hyperglycemia existing in diabetic islet, human ISC could 
transform to the activated state and synthesize and secret excessive ECM, which 
subsequently contribute to islet fibrosis in diabetic patients. 
It is interesting that similar cell was isolated from chick islets by S.P. Datar [31]. They 
isolated ISC from the chick islets and their results showed chick ISC was positive for 
desmin, vimentin and fibronectin. In their report, chick ISC could be differentiated 
into islet-like clusters, which was highly sensitive to l-arginine and less sensitive to 
glucose [31]. In contrast, our adipogenic and osteogenic differentiation experiment 
showed both the human PSC and ISC were capable of differentiating to adipocytes 
and osteocytes, it seems stellate cell may serve as pancreatic precursor cell. This idea 
could be confirmed by the report from B. Davani. They described the proliferative 
cells from human islet as islet-derived precursor cells (hIPCs) , which express CD73, 
CD90, and CD105, and can be differentiated in vitro into adipocytes, chondrocytes, 
and osteocytes. They concluded that hIPCs were a specific type of pancreas-derived 
mesenchymal stromal cells (MSCs). However, in addition to the MSC, our current 
study shows islet-derived cells also express PSC’s markers. In view of PSC’s function, 
ISC may have the potential to contribute to the islet fibrosis in T2DM. 
In conclusion, similar to our previous rat experiment, the current study shows that 
human islets also contain ISC which is phenotypically similar but not identical to 
human PSC. Activated human ISC is a high active ECM-producing cell type, 
indicating human ISC may contribute to islet fibrosis in patients with T2DM. 
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